Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 28:924-934
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrucci, E
Right arrow Articles by Cerutti, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrucci, E
Right arrow Articles by Cerutti, S

Assessment of heart rate variability changes during dipyridamole infusion and dipyridamole-induced myocardial ischemia: a time variant spectral approach

E Petrucci, LT Mainardi, V Balian, S Ghiringhelli, AM Bianchi, M Bertinelli, M Mainardi, and S Cerutti

Research Group on Hypertension and Computer Techniques in Cardiology, Bellini Hospital, Somma Lombardo, Varese, Italy.

OBJECTIVES: We sought to evaluate changes in RR interval variability during dipyridamole infusion and dipyridamole-induced myocardial ischemia. BACKGROUND: Myocardial ischemia and the autonomic nervous system can be mutually interdependent. Spectral analysis of RR interval variability is a useful tool in assessing autonomic tone. METHODS: We used a time variant autoregressive spectral estimation algorithm that could extract spectral variables even in the presence of nonstationary signals. Two groups were considered: group A (patients with ischemia, n = 15) with effort or mixed angina, angiographically assessed coronary artery disease and positive exercise and dipyridamole echocardiographic test results, and group B (control subjects, n = 10) with normal exercise and dipyridamole echocardiographic test results. We investigated the following variables: RR interval mean and variance, low frequency (LF) and high frequency (HF) power in normalized units, LF ratio (LF/LFbasal power), HF ratio (HF/HFbasal power) and LF/HF ratio. For each test epoch, we calculated for group A and group B the mean value +/- SE of all indexes considered. Differences due to an effect either of group (ischemic vs. control) or of time (including both drug and ischemia effects) were analyzed by using analysis of variance for repeated measurements. RESULTS: Dipyridamole injection was characterized by a reduction of all spectral components in negative test. The LF ratio was the only variable able to discriminate patients with ischemia from control subjects (p < 0.05), whereas a time effect was evident for both mean RR interval and high frequency power in normalized units (p < 0.05). The LF ratio decreased in group B from 1 +/- 0.00 (basal) to 0.31 +/- 0.22 (peak), and increased in group A from 1 +/- 0.00 to 15.41 +/- 6.59, respectively. Results of an unpaired t test comparing the peak values of the two groups were also statistically significant (p < 0.01). CONCLUSIONS: Our data show that time variant analysis of heart rate variability evidences an increase in the low frequency ratio that allows differentiation of positive from negative test results, suggesting that the electrocardiogram may contain ischemia information unrelated to ST-T variations, even if their enhancement requires a more complex data processing procedure.


This article has been cited by other articles:


Home page
Phil Trans R Soc AHome page
L. T Mainardi
On the quantification of heart rate variability spectral parameters using time-frequency and time-varying methods
Phil Trans R Soc A, January 28, 2009; 367(1887): 255 - 275.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement